Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 753,804 shares at $9.49 ($7.5M) on 2016-06-07, disclosed to the SEC on 2016-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.31 | 215,151 | $2.2M | 29.6% |
| 2 | $10.31 | 215,151 | $2.2M | 29.6% |
| 3 | $9.49 | 161,751 | $1.5M | 20.4% |
| 4 | $9.49 | 161,751 | $1.5M | 20.4% |
| Total | $9.96 avg | 753,804 | $7.5M | 100% |
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |